Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Joyce Lee

Concepts (354)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Diseases, Interstitial
67
2026
664
12.930
 Why?
Idiopathic Pulmonary Fibrosis
63
2026
692
11.220
 Why?
Arthritis, Rheumatoid
26
2026
1180
4.810
 Why?
Scleroderma, Systemic
10
2025
123
2.410
 Why?
Immunosuppressive Agents
9
2025
838
2.030
 Why?
Connective Tissue Diseases
9
2021
85
1.690
 Why?
Cryptogenic Organizing Pneumonia
2
2025
20
1.630
 Why?
Lung
28
2025
4116
1.630
 Why?
Mucin-5B
5
2025
234
1.520
 Why?
Vital Capacity
19
2025
292
1.510
 Why?
Tomography, X-Ray Computed
28
2025
2770
1.460
 Why?
Autoimmune Diseases
11
2025
469
1.460
 Why?
Adrenal Cortex Hormones
4
2025
484
1.370
 Why?
Disease Progression
14
2025
2865
1.360
 Why?
Gastroesophageal Reflux
5
2020
237
1.230
 Why?
Rheumatic Diseases
5
2024
98
1.190
 Why?
Pulmonary Fibrosis
10
2025
395
1.140
 Why?
Prognosis
24
2025
4330
1.130
 Why?
Humans
136
2026
145783
1.010
 Why?
Myositis
5
2025
57
0.980
 Why?
Alveolitis, Extrinsic Allergic
6
2022
93
0.960
 Why?
Respiratory Aspiration
4
2020
32
0.910
 Why?
Biomarkers
12
2025
4302
0.890
 Why?
Telomere
3
2025
287
0.870
 Why?
Aged
54
2026
26217
0.840
 Why?
Middle Aged
58
2026
36309
0.840
 Why?
Idiopathic Interstitial Pneumonias
4
2019
44
0.830
 Why?
Quality of Life
4
2024
3211
0.800
 Why?
Diagnosis, Differential
10
2025
1512
0.770
 Why?
Telomerase
2
2023
246
0.750
 Why?
Carcinoma, Hepatocellular
5
2025
373
0.740
 Why?
Pulmonary Surfactants
1
2023
105
0.740
 Why?
Histamine H2 Antagonists
2
2013
23
0.720
 Why?
Glucocorticoids
3
2024
532
0.710
 Why?
Matrix Metalloproteinase 7
1
2021
25
0.700
 Why?
Respiratory Function Tests
11
2025
544
0.680
 Why?
Proton Pump Inhibitors
2
2013
109
0.680
 Why?
Male
71
2026
73010
0.670
 Why?
Proteomics
3
2025
1188
0.650
 Why?
Rheumatology
5
2024
133
0.640
 Why?
Lung Transplantation
10
2025
332
0.620
 Why?
Female
70
2026
79045
0.610
 Why?
Cellular Senescence
1
2021
226
0.560
 Why?
Telomere Shortening
3
2025
19
0.540
 Why?
Genetic Predisposition to Disease
3
2026
2399
0.530
 Why?
Liver Neoplasms
5
2025
777
0.530
 Why?
Prospective Studies
13
2025
8078
0.510
 Why?
Severity of Illness Index
10
2025
2933
0.490
 Why?
Abatacept
3
2025
56
0.490
 Why?
Dyspnea
5
2023
250
0.480
 Why?
Patient Satisfaction
2
2021
712
0.470
 Why?
Forecasting
1
2017
390
0.460
 Why?
Survival Rate
11
2025
2094
0.460
 Why?
Risk Assessment
10
2021
3752
0.450
 Why?
Longitudinal Studies
8
2017
2968
0.410
 Why?
Cohort Studies
13
2025
6033
0.400
 Why?
Azathioprine
2
2024
44
0.390
 Why?
Patient Education as Topic
2
2016
777
0.390
 Why?
Pulmonary Diffusing Capacity
5
2020
78
0.380
 Why?
Early Diagnosis
2
2025
251
0.370
 Why?
Precision Medicine
1
2017
461
0.370
 Why?
Rituximab
2
2024
210
0.360
 Why?
Hypertension, Pulmonary
3
2022
1957
0.360
 Why?
Pepsin A
1
2011
18
0.350
 Why?
Antirheumatic Agents
4
2024
307
0.350
 Why?
Comprehensive Health Care
1
2011
22
0.340
 Why?
Fundoplication
1
2011
52
0.330
 Why?
Sleep Apnea, Obstructive
1
2015
303
0.330
 Why?
Carbon Monoxide
4
2019
82
0.310
 Why?
Veterans
4
2023
1642
0.310
 Why?
Bronchoalveolar Lavage Fluid
2
2011
638
0.300
 Why?
Endotoxins
1
2010
217
0.300
 Why?
Forced Expiratory Volume
4
2025
450
0.300
 Why?
Sirolimus
1
2011
282
0.300
 Why?
Proportional Hazards Models
7
2024
1330
0.300
 Why?
Phenotype
6
2025
3170
0.290
 Why?
Anti-Bacterial Agents
1
2019
1925
0.280
 Why?
Walk Test
2
2025
82
0.270
 Why?
United States
17
2025
16126
0.270
 Why?
Biopsy
5
2025
1082
0.270
 Why?
Risk Factors
12
2026
10919
0.270
 Why?
Retrospective Studies
16
2024
17330
0.260
 Why?
Emphysema
2
2022
100
0.260
 Why?
Mycophenolic Acid
3
2024
119
0.260
 Why?
Acute Lung Injury
1
2010
307
0.250
 Why?
Lung Diseases
3
2020
782
0.250
 Why?
Comorbidity
5
2015
1662
0.250
 Why?
Autoantibodies
2
2015
1509
0.230
 Why?
Prevalence
5
2022
2875
0.230
 Why?
Cancer-Associated Fibroblasts
1
2025
23
0.230
 Why?
Immunotherapy
3
2025
668
0.230
 Why?
Depression
1
2015
1559
0.230
 Why?
Predictive Value of Tests
4
2017
2123
0.220
 Why?
Pulmonologists
1
2025
14
0.220
 Why?
Thoracic Surgery, Video-Assisted
1
2025
56
0.220
 Why?
Yttrium Radioisotopes
2
2023
63
0.220
 Why?
Mutation
3
2023
4090
0.220
 Why?
Pyridones
2
2024
209
0.220
 Why?
Antineoplastic Agents, Phytogenic
1
2026
178
0.220
 Why?
Paclitaxel
1
2026
259
0.220
 Why?
Sex Factors
4
2020
2110
0.210
 Why?
Aged, 80 and over
10
2024
8347
0.210
 Why?
Case-Control Studies
6
2021
3634
0.200
 Why?
Endothelium, Vascular
1
2010
956
0.200
 Why?
Spirometry
3
2025
233
0.200
 Why?
Biopsy, Needle
3
2019
185
0.200
 Why?
Chronic Disease
6
2020
1812
0.200
 Why?
Exercise Tolerance
1
2025
283
0.200
 Why?
Pulmonary Emphysema
2
2025
277
0.200
 Why?
Sputum
1
2025
302
0.190
 Why?
Blood Proteins
1
2025
239
0.190
 Why?
Urinary Bladder Neoplasms
1
2026
258
0.190
 Why?
Fatty Liver
1
2025
253
0.190
 Why?
Polychlorinated Dibenzodioxins
1
2022
10
0.190
 Why?
Treatment Outcome
8
2025
11794
0.190
 Why?
Fibrosis
3
2022
561
0.180
 Why?
T-Lymphocytes, Regulatory
1
2025
411
0.180
 Why?
Transforming Growth Factor beta
1
2025
474
0.180
 Why?
Indoles
2
2024
507
0.180
 Why?
Genotype
2
2025
1857
0.180
 Why?
Recurrence
1
2025
1139
0.180
 Why?
Adult
19
2025
40881
0.180
 Why?
Genetic Testing
1
2025
483
0.170
 Why?
Self Care
2
2017
392
0.170
 Why?
Monocytes
2
2021
539
0.170
 Why?
Organizational Objectives
1
2021
67
0.170
 Why?
Incidence
5
2023
2934
0.170
 Why?
Nursing Research
1
2021
49
0.160
 Why?
Genetic Markers
1
2022
338
0.160
 Why?
Societies, Medical
5
2025
900
0.160
 Why?
Chemoembolization, Therapeutic
1
2021
89
0.160
 Why?
Kaplan-Meier Estimate
5
2017
971
0.160
 Why?
Smoking
3
2024
1477
0.160
 Why?
Patient Outcome Assessment
1
2021
130
0.160
 Why?
Chemokine CX3CL1
1
2020
25
0.160
 Why?
Immunohistochemistry
3
2019
1723
0.150
 Why?
Disease Models, Animal
1
2010
4568
0.150
 Why?
Survival Analysis
3
2012
1378
0.150
 Why?
Models, Organizational
1
2020
144
0.150
 Why?
Disease Management
4
2018
653
0.150
 Why?
Myositis, Inclusion Body
1
2019
11
0.150
 Why?
Graft Rejection
2
2020
521
0.150
 Why?
Radiography
2
2011
853
0.140
 Why?
Wnt-5a Protein
1
2018
25
0.140
 Why?
Gain of Function Mutation
1
2018
35
0.140
 Why?
Body Weight
1
2022
972
0.140
 Why?
Immunity, Innate
1
2024
835
0.140
 Why?
Ambulatory Care Facilities
1
2020
269
0.130
 Why?
Hypoxia
1
2025
1199
0.130
 Why?
Signal Transduction
2
2023
5224
0.130
 Why?
Focus Groups
2
2020
572
0.130
 Why?
Randomized Controlled Trials as Topic
1
2024
1752
0.130
 Why?
International Cooperation
1
2017
197
0.120
 Why?
Weight Loss
1
2022
859
0.120
 Why?
Myofibroblasts
1
2018
149
0.120
 Why?
Amino Acyl-tRNA Synthetases
1
2016
32
0.120
 Why?
Health Status Indicators
1
2017
167
0.120
 Why?
Women's Health
1
2018
316
0.120
 Why?
Patient-Centered Care
1
2021
547
0.120
 Why?
Extracellular Vesicles
1
2018
171
0.120
 Why?
Tomography Scanners, X-Ray Computed
1
2015
21
0.110
 Why?
Practice Patterns, Physicians'
1
2025
1372
0.110
 Why?
Acute Disease
3
2016
1036
0.110
 Why?
Follow-Up Studies
4
2019
5428
0.110
 Why?
Sarcoidosis
1
2017
163
0.110
 Why?
Cause of Death
1
2017
472
0.110
 Why?
Pulmonary Medicine
1
2015
78
0.110
 Why?
Antibiotic Prophylaxis
1
2016
134
0.110
 Why?
Nails
1
2014
14
0.100
 Why?
Sleep Wake Disorders
1
2018
314
0.100
 Why?
Hyperpigmentation
1
2014
27
0.100
 Why?
Hospitalization
1
2025
2461
0.100
 Why?
Bronchodilator Agents
1
2015
187
0.100
 Why?
Body Mass Index
1
2022
2447
0.100
 Why?
Oxygen Inhalation Therapy
1
2016
181
0.100
 Why?
Laparoscopy
1
2018
481
0.100
 Why?
Gene Expression Profiling
1
2020
1777
0.100
 Why?
Arsenic
1
2014
65
0.100
 Why?
Interleukin-13
1
2014
146
0.100
 Why?
Diagnostic Imaging
1
2016
337
0.100
 Why?
Age Factors
3
2019
3346
0.100
 Why?
Keratin-18
1
2012
12
0.090
 Why?
Counseling
1
2016
401
0.090
 Why?
Cystic Fibrosis
1
2023
1163
0.090
 Why?
Autoimmunity
2
2015
933
0.090
 Why?
Maternal Exposure
1
2014
189
0.090
 Why?
Microspheres
2
2023
142
0.090
 Why?
Interviews as Topic
1
2016
916
0.090
 Why?
Mass Screening
3
2026
1361
0.090
 Why?
Fatigue
1
2014
366
0.090
 Why?
Sjogren's Syndrome
2
2024
37
0.090
 Why?
Age Distribution
3
2019
404
0.090
 Why?
Time Factors
2
2024
7134
0.080
 Why?
Dermatitis, Atopic
1
2014
322
0.080
 Why?
Algorithms
2
2016
1851
0.080
 Why?
Everolimus
1
2011
112
0.080
 Why?
Epithelial Cells
2
2014
1134
0.080
 Why?
Programmed Cell Death 1 Receptor
2
2023
266
0.080
 Why?
Tumor Microenvironment
2
2025
735
0.080
 Why?
Sodium-Potassium-Exchanging ATPase
1
2010
55
0.080
 Why?
Animals
7
2025
38101
0.080
 Why?
Goals
1
2011
185
0.080
 Why?
Fetus
1
2014
804
0.070
 Why?
Leukocytes
2
2025
296
0.070
 Why?
Delphi Technique
2
2022
333
0.070
 Why?
Alveolar Epithelial Cells
1
2010
121
0.070
 Why?
Singapore
2
2021
27
0.070
 Why?
Health Status
1
2014
835
0.070
 Why?
Sensitivity and Specificity
1
2013
2000
0.070
 Why?
Virus Diseases
1
2011
216
0.070
 Why?
Qualitative Research
1
2016
1683
0.070
 Why?
Syndrome
2
2022
381
0.070
 Why?
Models, Statistical
1
2012
672
0.070
 Why?
Proto-Oncogene Proteins c-akt
1
2010
440
0.070
 Why?
DNA
1
2014
1437
0.060
 Why?
Multivariate Analysis
2
2025
1547
0.060
 Why?
Pulmonary Alveoli
2
2025
387
0.060
 Why?
Antibodies, Monoclonal
1
2014
1505
0.060
 Why?
Cell Membrane
1
2010
709
0.060
 Why?
Micelles
1
2026
39
0.060
 Why?
Internationality
2
2017
156
0.060
 Why?
Japan
1
2026
149
0.060
 Why?
France
1
2025
40
0.060
 Why?
Pulmonary Surfactant-Associated Protein D
1
2025
31
0.060
 Why?
Promoter Regions, Genetic
2
2021
1247
0.060
 Why?
Methotrexate
2
2021
233
0.050
 Why?
Logistic Models
2
2025
2139
0.050
 Why?
Genetic Loci
1
2026
267
0.050
 Why?
Cyclophosphamide
1
2025
272
0.050
 Why?
Mixed Connective Tissue Disease
1
2024
10
0.050
 Why?
Pandemics
2
2024
1711
0.050
 Why?
Prednisone
2
2019
226
0.050
 Why?
Sex Distribution
2
2015
388
0.050
 Why?
Mice
3
2025
18355
0.050
 Why?
Professional Practice Gaps
1
2023
15
0.050
 Why?
Demography
1
2024
282
0.050
 Why?
Adaptive Immunity
1
2024
167
0.050
 Why?
Chromosome Deletion
1
2023
126
0.050
 Why?
CD3 Complex
1
2023
112
0.050
 Why?
Agent Orange
1
2022
3
0.050
 Why?
2,4,5-Trichlorophenoxyacetic Acid
1
2022
3
0.050
 Why?
Palliative Care
1
2011
1022
0.050
 Why?
2,4-Dichlorophenoxyacetic Acid
1
2022
14
0.050
 Why?
CTLA-4 Antigen
1
2023
105
0.050
 Why?
Antibody Formation
1
2024
288
0.050
 Why?
Respiratory Mucosa
1
2025
322
0.040
 Why?
Whole Genome Sequencing
1
2023
178
0.040
 Why?
Exome
1
2023
229
0.040
 Why?
Probability
1
2022
308
0.040
 Why?
Patient Reported Outcome Measures
1
2025
498
0.040
 Why?
Administration, Intravenous
1
2021
172
0.040
 Why?
Double-Blind Method
1
2025
2064
0.040
 Why?
Leukocytes, Mononuclear
1
2023
574
0.040
 Why?
Family
1
2025
685
0.040
 Why?
Evidence-Based Medicine
1
2024
740
0.040
 Why?
Bayes Theorem
1
2022
421
0.040
 Why?
CX3C Chemokine Receptor 1
1
2020
19
0.040
 Why?
Total Lung Capacity
1
2019
29
0.040
 Why?
Pilot Projects
1
2025
1898
0.040
 Why?
Immunologic Factors
1
2022
260
0.040
 Why?
Allografts
1
2020
152
0.040
 Why?
Drug Discovery
1
2020
153
0.040
 Why?
Antibodies, Viral
1
2024
674
0.040
 Why?
Mice, Inbred C57BL
1
2010
5992
0.040
 Why?
Safety
1
2021
358
0.040
 Why?
Genome-Wide Association Study
1
2026
1430
0.040
 Why?
Cross-Sectional Studies
2
2025
5925
0.040
 Why?
Fibroblasts
1
2025
1028
0.040
 Why?
Ireland
1
2019
32
0.040
 Why?
Embolization, Therapeutic
1
2021
243
0.040
 Why?
Dermatomyositis
1
2019
24
0.040
 Why?
Insulin
1
2010
2516
0.040
 Why?
Echocardiography
1
2022
648
0.040
 Why?
Polymorphism, Single Nucleotide
1
2026
2181
0.030
 Why?
Rare Diseases
1
2019
116
0.030
 Why?
Combined Modality Therapy
1
2021
1271
0.030
 Why?
Hydrogen-Ion Concentration
1
2020
532
0.030
 Why?
Intention to Treat Analysis
1
2018
79
0.030
 Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2018
103
0.030
 Why?
Behavior
1
2018
90
0.030
 Why?
Education
1
2018
105
0.030
 Why?
Morbidity
1
2018
322
0.030
 Why?
United Kingdom
1
2019
358
0.030
 Why?
Sleep Apnea Syndromes
1
2018
98
0.030
 Why?
CD8-Positive T-Lymphocytes
1
2023
923
0.030
 Why?
Medicare
1
2023
904
0.030
 Why?
Linear Models
1
2019
849
0.030
 Why?
Registries
1
2025
2410
0.030
 Why?
Antibodies, Antinuclear
1
2016
62
0.030
 Why?
Comprehension
1
2018
187
0.030
 Why?
Muscle Strength
1
2019
332
0.030
 Why?
Flow Cytometry
1
2020
1165
0.030
 Why?
Odds Ratio
1
2018
1083
0.030
 Why?
Gene Expression
1
2020
1478
0.030
 Why?
California
1
2017
473
0.030
 Why?
Evaluation Studies as Topic
1
2015
164
0.030
 Why?
Global Health
1
2018
403
0.030
 Why?
Pneumonia, Aspiration
1
2015
16
0.030
 Why?
Monitoring, Physiologic
1
2017
289
0.030
 Why?
Vaccination
1
2024
1428
0.030
 Why?
Recovery of Function
1
2019
716
0.030
 Why?
Bronchiolitis Obliterans
1
2015
61
0.030
 Why?
Regression Analysis
1
2017
1001
0.030
 Why?
Sampling Studies
1
2014
98
0.030
 Why?
San Francisco
1
2014
60
0.030
 Why?
Chicago
1
2014
62
0.030
 Why?
Europe
1
2015
421
0.030
 Why?
Neck
1
2014
109
0.030
 Why?
Patient Acuity
1
2013
48
0.020
 Why?
Endothelial Cells
1
2020
878
0.020
 Why?
Texas
1
2014
273
0.020
 Why?
Mice, SCID
1
2014
369
0.020
 Why?
Observational Studies as Topic
1
2013
134
0.020
 Why?
Enzyme Inhibitors
1
2016
821
0.020
 Why?
Protein Kinase Inhibitors
1
2019
981
0.020
 Why?
Developing Countries
1
2014
317
0.020
 Why?
Surveys and Questionnaires
1
2025
6085
0.020
 Why?
Young Adult
2
2022
14254
0.020
 Why?
Endoplasmic Reticulum Stress
1
2012
118
0.020
 Why?
Torque teno virus
1
2011
1
0.020
 Why?
DNA Virus Infections
1
2011
3
0.020
 Why?
Academic Medical Centers
1
2014
554
0.020
 Why?
Up-Regulation
1
2014
848
0.020
 Why?
Cells, Cultured
1
2018
4151
0.020
 Why?
Molecular Targeted Therapy
1
2014
441
0.020
 Why?
Pulmonary Disease, Chronic Obstructive
1
2018
920
0.020
 Why?
Mass Spectrometry
1
2014
732
0.020
 Why?
Microarray Analysis
1
2011
117
0.020
 Why?
Models, Theoretical
1
2014
560
0.020
 Why?
Colorado
1
2020
4556
0.020
 Why?
Subcellular Fractions
1
2010
73
0.020
 Why?
GTPase-Activating Proteins
1
2010
81
0.020
 Why?
Body Fluids
1
2010
71
0.020
 Why?
Practice Guidelines as Topic
1
2017
1582
0.020
 Why?
rab GTP-Binding Proteins
1
2010
76
0.020
 Why?
Adolescent
2
2022
22577
0.020
 Why?
Reproducibility of Results
1
2017
3418
0.020
 Why?
Inflammation
1
2020
2884
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2011
751
0.020
 Why?
Models, Biological
1
2016
1764
0.020
 Why?
Protein Transport
1
2010
442
0.020
 Why?
Sequence Analysis, DNA
1
2011
778
0.020
 Why?
Polymerase Chain Reaction
1
2011
1043
0.020
 Why?
Phosphatidylinositol 3-Kinases
1
2010
383
0.020
 Why?
Telemedicine
1
2017
967
0.020
 Why?
Cattle
1
2010
946
0.020
 Why?
Asthma
1
2018
1797
0.020
 Why?
Respiratory Tract Infections
1
2011
396
0.020
 Why?
Rats, Sprague-Dawley
1
2010
2525
0.010
 Why?
Apoptosis
1
2012
2444
0.010
 Why?
Rats
1
2010
5585
0.010
 Why?
Pregnancy
1
2014
7216
0.010
 Why?
Infant
1
2014
10091
0.010
 Why?
Child
1
2014
22740
0.010
 Why?
Lee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (354) concept(s)
_
Co-Authors Expand Description
See all (32) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)